Acetazolamide description: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Acetazolamide}} {{CMG}}; {{AE}} {{SS}} ==Description== DIAMOX SEQUELS (Acetazolamide Extended-Release Capsules) are an inhibitor of the enzyme carbonic anhydrase....")
 
(Redirected page to Acetazolamide#Structure)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Acetazolamide#Structure]]
{{Acetazolamide}}
{{CMG}}; {{AE}} {{SS}}
 
==Description==
DIAMOX SEQUELS (Acetazolamide Extended-Release Capsules) are an inhibitor of the enzyme carbonic anhydrase.
 
DIAMOX is a white to faintly yellowish white crystalline, odorless powder, weakly acidic, very slightly soluble in water, and slightly soluble in alcohol. The chemical name for DIAMOX is N-(5-Sulfamoyl-1,3, 4-thiadiazol-2-yl) acetamide and has the following chemical structure:
 
{|
|[[File:acetazolamide01.jpg|thumb|800px]]
|}
 
DIAMOX SEQUELS are extended-release capsules, for oral administration, each containing 500 mg of acetazolamide and the following inactive ingredients:
 
Microcrystalline cellulose, sodium lauryl sulfate and talc.
 
The ingredients in the capsule shell are D&C red no. 28, D&C yellow no. 10, FD&C red no. 40, gelatin and titanium dioxide.
 
The ingredients in the imprinting ink are D&C yellow no. 10 aluminum lake, FD&C blue no. 1 aluminum lake, FD&C blue no. 2 aluminum lake, FD&C red no. 40 aluminum lake, pharmaceutical glaze, propylene glycol and synthetic iron oxide.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = DIAMOX SEQUELS (ACETAZOLAMIDE) CAPSULE, EXTENDED RELEASE [DURAMED PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74e47451-2bc8-496e-88ad-c10002ee8e22 | publisher =  | date =  | accessdate = 25 February 2014 }}</ref>
 
==References==
{{reflist|2}}
 
{{Anticonvulsants}}
{{Antiglaucoma preparations and miotics}}
{{Diuretics}}
 
[[Category:Carbonic anhydrase inhibitors]]
[[Category:Mountaineering and health]]
[[Category:Anticonvulsants]]
[[Category:Sulfonamides]]
[[Category:World Health Organization essential medicines]]
[[Category:Thiadiazoles]]
[[Category:Amides]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 15:07, 21 July 2014